The National Health Service (NHS) is set to distribute sepsis sensors to patients in a move that aims to prevent around 1,000 deaths annually. These sensors, integrated into mobile phone apps, watches, or bracelets, will help identify early signs of sepsis, a severe response to infection. By monitoring vital signs post-hospital discharge, the devices will automatically alert healthcare providers if a patient’s condition worsens, indicating a need for sepsis testing.
Healthcare professionals emphasize the critical role of wearable technology in saving lives, highlighting that prompt sepsis treatment significantly reduces mortality risks. Professor Ramani Moonesinghe, NHS England’s Deputy Medical Director, stressed the importance of early sepsis detection, as delays can hinder recovery chances. The NHS plans to pilot new wearable devices for at-home vital sign monitoring to enhance early intervention.
Sepsis, a leading cause of mortality, contributes to thousands of deaths annually in the UK. The UK Sepsis Trust estimates that sepsis is a factor in approximately 48,000 deaths each year, with 4,000 directly attributed to sepsis in England. Improved care practices could prevent a quarter of these deaths, according to NHS leaders.
Symptoms of sepsis often stem from bacterial infections and may include confusion, shivering, muscle pain, and breathing difficulties in adults. Children and infants may exhibit rapid breathing, temperature fluctuations, skin discoloration, lethargy, and vomiting. Recognizing these signs early is crucial in preventing fatalities.
Minister for patient safety, Preet Gill, highlighted the devastating impact of sepsis and the importance of swift recognition and response to deterioration. Efforts to promote patient safety and enhance care quality have been supported by families affected by sepsis, driving improvements in healthcare practices.
Several hospitals have already started implementing wearable technology to monitor at-risk inpatients for sepsis. For instance, cancer patients undergoing CAR T cell therapy at University College London Hospitals wear devices to track heart rate, respiratory rate, and temperature, key indicators of sepsis and cytokine release syndrome.
The introduction of wearable technology is part of the ‘Modern Service Framework’ plan for sepsis, designed to enhance patient outcomes. Dr. Ron Daniels, founder of the UK Sepsis Trust, praised the plan for its advancements in patient safety and potential to save more lives from sepsis.
For further information on sepsis and its warning signs, visit nhs.uk/sepsis.